U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07106814) titled 'Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes(Meta 10-TIL)for the Treatment of Advanced Solid Tumors' on July 30.

Brief Summary: A Study of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) Therapy for Patients With Advanced Solid Tumors

Study Start Date: Aug. 15

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: Metabolically Armed TIL cells

Each subject receive metabolically armed TIL cells by intravenous infusion.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Anhui Provincial Hospital

Disclaimer: Curated by HT Syndication....